Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CHAT | P28329 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3269032 | 0.82 | RELA (0.46) | RELAALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL5136337 | 0.74 | L3MBTL1 (0.41) | RELAALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL7220051 | 0.74 | ALDH1A1 (0.46) | RELAALDH1A1TSHRMAOBCYP2A6 | |
| Trimethylammonium SCHEMBL27686011 | 0.73 | RELA (0.48) | RELAALDH1A1TSHRMAOBCYP2A6 | |
| (Z)-1,2-Diphenylethene SCHEMBL27459562 | 0.73 | RELA (0.68) | RELAALDH1A1MAOBGRM5CHAT | |
| SCHEMBL9248249 | 0.72 | AKR1C3 (0.43) | RELAALDH1A1TSHRCYP2A6LMNA | |
| SCHEMBL81307 | 0.72 | RELA (0.54) | RELAALDH1A1MAOBGRM5LMNA | |
| SCHEMBL6218827 | 0.72 | MAPT (0.50) | ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL4698865 | 0.72 | RELA (0.43) | RELAALDH1A1TSHRMAOBCYP2A6 | |
| SCHEMBL8906413 | 0.72 | HSD17B10 (0.46) | ALDH1A1MAOBCYP2A6LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 861 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716386-A | Novel exosome inhibitor and preparation method thereof | 北京和理咨询有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-113874375-A | Cyclic amide compounds and methods thereof for the treatment of rabies | 株式会社大分大学先端医学研究所 | 2021-12-31 | — | — | CN | claimed |
| WO-2020246503-A1 | CYCLIC AMIDE COMPOUNDS FOR RABIES TREATMENT AND METHOD THEREOF | 株式会社大分大学先端医学研究所 | 2020-12-10 | — | — | WO | claimed |
| CN-110483531-A | A kind of water-soluble porphyrin ene derivative, preparation method, anti-tumor drug and application | LI DEFANG | 2019-11-22 | — | — | CN | claimed |
| EP-3196193-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE VALERIC ACID DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2018-12-19 | — | — | EP | claimed |
| CN-105326809-B | One kind containing CaCO3The preparation method of the composite natral high molecule microcapsule of particle | 武汉理工大学 | 2018-08-07 | — | — | CN | claimed |
| US-9938242-B2 | Methods for producing optically active valeric acid derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-04-10 | — | — | US | claimed |
| CN-107847607-A | Aptamer conjugate of paclitaxel or derivative thereof, and preparation method and application thereof | 北京和理咨询有限公司 | 2018-03-27 | — | — | CN | claimed |
| US-9809822-B2 | Triptolide derivatives and preparation method and use thereof | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-11-07 | — | — | US | claimed |
| US-20170291878-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE VALERIC ACID DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-10-12 | — | — | US | claimed |
| WO-1996008497-A1 | METAL (III) COMPLEXES CONTAINING, NON-AROMATIC, ANIONIC, DIENYL GROUPS AND ADDITION POLYMERIZATION CATALYSTS THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1996-03-21 | — | — | WO | claimed |
| EP-0656075-A1 | ELECTROCHEMICAL PREPARATION OF ADDITION POLYMERIZATION CATALYSTS | THE DOW CHEMICAL COMPANY (US) | 1995-06-07 | — | — | EP | claimed |
| US-5322844-A | Cardiovascular disorders, antiinflammatory agents, antiallergens | GODECKE AKTIENGESELLSCHAFT (DE) | 1994-06-21 | — | — | US | claimed |
| US-5185352-A | Treating or preventing cardiovascular disorders | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | claimed |
| EP-0427765-A1 | ALKOXY-4(1H)-PYRIDONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USE AS DRUGS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1991-05-22 | — | — | EP | claimed |
| US-4976889-A | 4-formylaminopiperidine derivatives, their use as stabilizers and organic material stabilized with the said derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1990-12-11 | — | — | US | claimed |
| CN-1040193-A | The preparation of alkoxyl group-4 (1H)-Pyridione derivatives | GOEDECKE AG (DE) | 1990-03-07 | — | — | CN | claimed |
| WO-1990001477-A1 | ALKOXY-4(1H)-PYRIDONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USE AS DRUGS | Gödecke Aktiengesellschaft (DE) | 1990-02-22 | — | — | WO | claimed |
| EP-0354495-A1 | Alkoxy-4(1H)-pyridone derivatives, process for their preparation and their pharmaceutical use | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1990-02-14 | — | — | EP | claimed |
| US-3993643-A | ANTISCHISTOSOMAL | STANFORD RESEARCH INSTITUTE (US) | 1976-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170291878-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE VALERIC ACID DERIVATIVE | ALAD, GRHPR, ME1 | RELA 894/4885ALDH1A1 1178/4885TSHR 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.